Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 305, Issue 4, 2013, Pages

  Yang, Jun ^a   Li, Xiaohui ^b   Li, Ying ^b   Southwood, Mark ^a   Ye, Lingying ^c   Long, Lu ^a   Al Lamki, Rafia S ^a   Morrell, Nicholas W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein type II receptor; Cell cycle; Id; Pulmonary arterial smooth muscle cell; Pulmonary hypertension

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CYTOKINE; GROWTH FACTOR; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; INHIBITOR OF DIFFERENTIATION 4; INHIBITOR OF DIFFERENTIATION PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR; CELL CYCLE; ID; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; CELL CYCLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; INHIBITOR OF DIFFERENTIATION PROTEINS; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, MUTANT STRAINS; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84881636538     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00054.2013     Document Type: Article

References (42)

1. Aldred MA, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez MA, Martensson G, Galie N, Manes A, Corris P, Simonneau G, Humbert M, Morrell NW, Trembath RC. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat 27: 212-213, 2006.
2. Al-Lamki RS, Wang J, Vandenabeele P, Bradley JA, Thiru S, Luo D, Min W, Pober JS, Bradley JR. TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 19: 1637-1645, 2005.
3. Caruso P, Dempsie Y, Stevens HC, McDonald RA, Long L, Lu RF, White K, Mair KM, McClure JD, Southwood M, Upton P, Xin M, van Rooij E, Olson EN, Morrell NW, MacLean MR, Baker AH. A role for miR-145 in pulmonary arterial hypertension evidence from mouse models and patient samples. Circ Res 111: 290-300, 2012.
4. Doran AC, Lehtinen AB, Meller N, Lipinski MJ, Slayton RP, Oldham SN, Skaflen MD, Yeboah J, Rich SS, Bowden DW, McNamara CA. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res 106: 1303, 2010.
5. Forrest S, McNamara C. Id family of transcription factors and vascular lesion formation. Arterioscler Thromb Vasc Biol 24: 2014-2020, 2004.
6. Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jaïs X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O'Callaghan DS, Simonneau G, Soubrier F, Humbert M. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 181: 851-861, 2010.
7. Grönroos E, Kingston IJ, Ramachandran A, Randall RA, Vizán P, Hill CS. Transforming growth factor (3 inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol 32: 2904-2916, 2012.
8. Ji M, Li HJ, Suh HC, Klarmann KD, Yokota Y, Keller JR. Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. Blood 112: 1068-1077, 2008.
9. Kim JH, Peacock MR, George SC, Hughes CC. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/Act-RII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. Angiogenesis 15: 497-509, 2012.
10. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26: 81-84, 2000.
11. Lasorella A, Uo T, Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene 20: 8326-8333, 2001.
12. Long L, MacLean MR, Jeffery TK, Morecroft I, Yang XD, Rudara-kanchana N, Southwood M, James V, Trembath RC, Morrell NW. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98: 818-827, 2006.
13. Long L, Crosby A, Yang XD, Southwood M, Upton PD, Kim DK, Morrell NW. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 119: 566, 2009.
14. Lowery JW, Frump AL, Anderson L, DiCarlo GE, Jones MT, de Caestecker MP. Id family protein expression and regulation in hypoxic pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol 299: R1463-R1477, 2010.
15. Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, Loyd JE, Newman JH, Phillips JA 3rd, Soubrier F, Trembath RC, Chung WK. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol Suppl 30: S32-S42, 2009.
16. Machado RD, Thomson JR, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Thorax 55: A23, 2000.
17. Massague J. TGF beta signalling in context. Nat Rev Mol Cell Biol 13: 616-630, 2012.
18. Matsumura ME, Lobe DR, McNamara CA. Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation. J Biol Chem 277: 7293-7297, 2002.
19. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Sci STKE 2002: E40, 2002.
20. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JXJ, Weir EK. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54: S20-S31, 2009.
21. Morrell NW, Morris KG, Stenmark KR. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 269: H1186-H1194, 1995.
22. Morrell NW, Yang X, Upton PD, Yacoub MH, Polak JM, Wharton J. Altered growth responses of human pulmonary artery smooth muscle and neointimal cells from patients with pulmonary hypertension. Am J Respir Crit Care Med 159: A696, 1999.
23. Nishiyama K, Takaji K, Kataoka K, Kurihara Y, Yoshimura M, Kato A, Ogawa H, Kurihara H. Id1 gene transfer confers angiogenic property on fully differentiated endothelial cells and contributes to therapeutic angiogenesis. Circulation 112: 2840-2850, 2005.
24. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113: 3897-3905, 2000.
25. Owens AP, Subramanian V, Moorleghen JJ, Guo ZH, McNamara CA, Cassis LA, Daugherty A. Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ Res 106: 611-619, 2010.
26. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 122: 4306-4313, 2012.
27. Rawlins EL, Clark CP, Xue Y, Hogan BLM. The Id2(+) distal tip lung epithelium contains individual multipotent embryonic progenitor cells. Development 136: 3741-3745, 2009.
28. Rudarakanchana N, Flanagan JA, Chen HL, Upton PD, Machado R, Patel D, Trembath RC, Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11: 1517-1525, 2002.
29. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 361: 1533-1544, 2003.
30. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 13: 410-418, 2003.
31. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 3: 525-530, 2003.
32. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, Walker C, Budd DC, Pepke-Zaba J, Morrell NW. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122: 920-927, 2010.
33. Song Y, Jones JE, Beppu H, Keaney JF Jr, Loscalzo J, Zhang YY. Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation 112: 553-562, 2005.
34. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, Newman J, Wheeler L, Higenbottam T, Gibbs JS, Egan J, Crozier A, Peacock A, Allcock R, Corris P, Loyd JE, Trembath RC, Nichols WC. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 37: 741-745, 2000.
35. Upton PD, Davies RJ, Trembath RC, Morrell NW. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem 284: 15794-15804, 2009.
36. Wharton J, Davie N, Upton PD, Yacoub MH, Polak JM, Morrell NW. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation 102: 3130-3136, 2000.
37. Yang J, Davies RJ, Southwood M, Long L, Yang XD, Sobolewski A, Upton PD, Trembath RC, Morrell NW. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells. Implications for familial pulmonary arterial hypertension. Circ Res 102: 1212-1221, 2008.
38. Yang J, Li XH, Al Lamki RS, Southwood M, Zhao J, Lever AM, Grimminger F, Schermuly RT, Morrell NW. Smad-Dependent and Smad-independent induction of Id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo. Circ Res 107: 252, 2010.
39. Yang J, Li X, Al-Lamki RS, Wu C, Weiss A, Berk J, Schermuly RT, Morrell NW. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension. Arterioscler Thromb Vasc Biol 33: 34-42, 2013.
40. Yang CY, Best JA, Knell J, Yang E, Sheridan AD, Jesionek AK, Li HYS, Rivera RR, Lind KC, D'Cruz LM, Watowich SS, Murre C, Goldrath AW. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8(+) T cell subsets. Nat Immunol 12: 1221, 2011.
41. Zhang S, Fantozzi I, Tigno DD, Yi ES, Platoshyn O, Thistlethwaite PA, Kriett JM, Yung G, Rubin LJ, Yuan JX. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285: L740-L754, 2003.
42. Zhang X, Ling MT, Wang Q, Lau CK, Leung SC, Lee TK, Cheung AL, Wong YC, Wang X. Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem 282: 33284-33294, 2007.